Abstract
CXCR7 is a receptor for chemokines including CXCL12 (stromal-derived factor-1), a molecule that promotes tumor growth and metastasis in breast cancer and other malignancies. Building on the recent observation that CXCR7 sequesters CXCL12, we investigated mechanisms for CXCR7-dependent uptake of chemokines. Breast cancer cells expressing CXCR7 accumulated chemokines CXCL12 and CXC11 present at concentrations <1 ng/ml, unlike cells expressing CXCR4. CXCR7-dependent accumulation of chemokines was reduced by inhibitors of clathrin-mediated endocytosis. After CXCR7-mediated internalization, CXCL12 trafficked to lysosomes and was degraded, although levels of CXCR7 remained stable. CXCR7 reduced CXCL12 in the extracellular space, limiting the amounts of chemokine available to acutely stimulate signaling through CXCR4. CXCR7 constitutively internalized and recycled to the cell membrane even in the absence of ligand, and addition of chemokines did not significantly enhance receptor internalization. Chemokines at concentrations less than the Kd values for ligand–receptor binding did not alter levels of CXCR7 at the cell surface. Higher concentrations of chemokine ligands reduced the total cell surface expression of CXCR7 without affecting receptor internalization, indicating that receptor recycling was inhibited. CXCR7-dependent uptake of chemokines and receptor trafficking were regulated by β-arrestin 2. These studies establish mechanisms through which CXCR7 regulates the availability of chemokine ligands in the extracellular space.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domerci J, Huang H et al. (2004). Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6: 17–32.
Atanackovic D, Cao Y, Kim J, Brandl S, Thorn I, Faltz C et al. (2008). The local cytokine and chemokine milieu within malignant effusions. Tumour Biol 29: 93–104.
Balabanian K, Lagane B, Infantino S, Chow K, Harriague J, Moepps B et al. (2005). The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 280: 35760–35766.
Balkwill F . (2004). Cancer and the chemokine network. Nat Rev Cancer 4: 540–550.
Boldajipour B, Mahabaleshwar S, Kardash E, Reichman-Fried M, Blaser H, Minina S et al. (2008). Control of chemokine-guided cell migration by ligand sequestration. Cell 132: 463–473.
Burns J, Summers B, Wang Y, Melikian A, Berahovich R, Miao Z et al. (2006). A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 203: 2201–2213.
Cox J, Dean R, Roberts C, Overall C . (2008). Matrix metalloproteinase processing of CXCL11/I-TAC results in loss of chemoattractant activity and altered glycosaminoglycan binding. J Biol Chem 283: 19389–19399.
Dar A, Goichberg P, Shinder V, Kalinkovich A, Kollet O, Netzer N et al. (2005). Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 6: 1038–1046.
Fermas S, Gonnet F, Sutton A, Charnaux N, Mulloy B, Du Y et al. (2008). Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis. Glycobiology 18: 1054–1064.
Furuya M, Suyama T, Usui H, Kasuya Y, Nishiyama M, Tanaka N et al. (2007). Up-regulation of CXC chemokines and their receptors: implications for proinflammatory microenvironments of ovarian carcinomas and endometriosis. Hum Pathol 37: 1676–1687.
Galliera E, Venkatakrishna R, Trent J, Bonecchi R, Signorelli P, Lefkowitz R et al. (2004). b-Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 279: 25590–25597.
Griesbeck O, Barid G, Campbell R, Zacharias D, Tsien R . (2001). Reducing the environmental sensitivity of yellow fluorescent protein. Mechanism and applications. J Biol Chem 276: 29188–29194.
Hansell C, Simpson C, Nibbs R . (2006). Chemokine sequestration by atypical chemokine receptors. Biochem Soc Trans 34: 1009–1013.
Heuser J, Anderson R . (1989). Hypertonic media inhibit receptor-mediated but not fluid-phase endocytosis by blocking clathrin-coated pit formation. J Cell Biol 108: 389–400.
Hoogewerf A, Kuschert G, Proudfoot A, Borlat F, Clark-Lewis I, Power C et al. (1997). Glycosaminoglycans mediate cell surface oligomerization of chemokine. Biochemistry 36: 13570–13578.
Kalatskaya I, Berchiche Y, Gravel S, Limberg B, Rosenbaum J, Heveker N . (2009). AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 75: 1240–1247.
Kang Y, Siegel P, Shu W, Drobnjak M, Kakonen S, Cordon-Cardo C et al. (2003). A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3: 537–549.
Kelly K, Narhendorf M, Yu A, Reynolds F, Weissleder R . (2006). in vivo phage display selection yields atherosclerotic plaque targeted peptides for imaging. Mol Imaging Biol 8: 1536–1632.
Kohout T, Lin F-T, Perry S, Conner D, Lefkowitz R . (2001). Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci USA 98: 1601–1606.
Kollmar O, Rupertus K, Scheuer C, Junker B, Tilton B, Schilling M et al. (2007). Stromal cell-derived factor-1 promotes cell migration and tumor growth of colorectal metastasis. Neoplasia 9: 862–870.
Laquri C, Sadir R, Rueda P, Baleux F, Gans P, Arenzana-Seisdedos F et al. (2007). The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. PLoS One 2: e1110.
Levoye A, Balabanian K, Baleux F, Bachelerie F, Lagane B . (2009). CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling. Blood 113: 6085–6093.
Lois C, Hong E, Pease S, Brown E, Baltimore D . (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295: 868–872.
Luker G, Pica C, Song J, Luker K, Piwnica-Worms D . (2003). Imaging 26S proteasome activity and inhibition in living mice. Nat Med 9: 969–973.
Luker K, Gupta M, Luker G . (2008). Imaging CXCR4 signaling with firefly luciferase complementation. Anal Chem 80: 5565–5573.
Luker K, Gupta M, Luker G . (2009a). Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7. Biotechniques 47: 625–632.
Luker K, Gupta M, Luker G . (2009b). Imaging chemokine receptor dimerization with firefly luciferase complementation. FASEB J 23: 823–834.
Luker K, Gupta M, Steele J, Foerster B, Luker G . (2009c). Imaging ligand-dependent activation of CXCR7. Neoplasia 11: 1022–1035.
Luker K, Luker G . (2006). Functions of CXCL12 and CXCR4 in breast cancer. Cancer Lett 238: 30–41.
Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T . (2006). Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10: 839–850.
Marchese A, Benovic J . (2001). Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem 276: 45509–45512.
Miao Z, Luker K, Summers B, Berahovich R, Bhojani M, Rehemtulla A et al. (2007). CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci USA 104: 15735–15740.
Muller A, Homey B, Soto H, Ge N, Catron D, Buchanon M et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50–56.
Naumann U, Cameroni E, Pruenster M, Mahabaleshwar S, Raz E, Zerwes H et al. (2010). CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS One 5: e9175.
Orimo A, Gupta P, Sgroi D, Arenzana-Seisdedos F, Delaunay T, Naeem R et al. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121: 335–348.
Proost P, Schutyser E, Menten P, Struyf S, Wuyts A, Opdenakker G et al. (2001). Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties. Blood 98: 3554–3561.
Pruenster M, Mudde L, Bombosi P, Dimitrova S, Zsak M, Middleton J et al. (2009). The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity. Nat Immunol 10: 101–108.
Raggo C, Ruhl R, McAllister S, Koon H, Dezube B, Fruh K et al. (2005). Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Cancer Res 65: 5084–5095.
Sadir R, Imberty A, Baleux F, Lortat-Jacob H . (2004). Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 279: 43854–43860.
Sharma V, Crankshaw C, Piwnica-Worms D . (1996). Effects of multidrug resistance (MDR1) P-glycoprotein expression levels and coordination metal on the cytotoxic potency of multidentate (N4O2) (ethylenediamine)bis[propyl(R-benzylimino)]metal(III) cations. J Med Chem 39: 3483–3490.
Shenoy S, Lefkowitz R . (2003). Multifaceted roles of beta-arrestins in the regulation of seven-membrane-spanning receptor trafficking and signalling. Biochem J 375: 503–515.
Sierro F, Biben C, Martinez-Munoz L, Mellado M, Rashohoff R, Li M et al. (2007). Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci USA 104: 14759–14764.
Smith M, Luker K, Garbow J, Prior J, Jackson E, Piwnica-Worms D et al. (2004). CXCR4 regulates growth of both primary and metastatic breast cancer. Cancer Res 64: 8604–8612.
Strieter R, Burdick M, Mestas J, Gomperts B, Keane M, Belperio J . (2006). Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42: 768–778.
van Weert A, Geuze H, Groothuis B, Stoorvogel W . (2000). Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direction intearction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur J Cell Biol 79: 394–399.
Vandercappellen J, Van Damme J, Struyf S . (2008). The role of CXC chemokines and their receptors in cancer. Cancer Lett 267: 226–244.
Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta K et al. (2008). The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 283: 4283–4294.
Weber M, Blair E, Simpson C, O'Hara M, Blackburn P, Rot A et al. (2004). The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell 15: 2492–2508.
Wu F, Ou Z, Feng L, Luo J, Wang L, Shen Z et al. (2008). Chemokine decoy receptor d6 plays a negative role in human breast cancer. Mol Cancer Res 6: 1276–1288.
Yang X, Chu Y, Wang Y, Guo Q, Xiong S . (2005). Vaccination with IFN-inducible T cell alpha chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells. Vaccine 24: 2966–2974.
Zabel B, Wang Y, Lewen S, Berahovich R, Penfold M, Zhang P et al. (2009). Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol 183: 3204–3211.
Zhang L, Yeger H, Das B, Irwin M, Baruchel S . (2007). Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma. Neoplasia 9: 36–46.
Zhao M, Mueller B, DiScipio R, Schraufstatter I . (2008). Akt plays an important role in breast cancer cell chemotaxis to CXCL12. Breast Cancer Res Treat 110: 211–222.
Acknowledgements
Research was supported by NIH grants R01CA136553, R01CA136829 and P50CA093990. We thank ChemoCentryx for mAb 11G8 and CCX733.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Luker, K., Steele, J., Mihalko, L. et al. Constitutive and chemokine-dependent internalization and recycling of CXCR7 in breast cancer cells to degrade chemokine ligands. Oncogene 29, 4599–4610 (2010). https://doi.org/10.1038/onc.2010.212
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.212
Keywords
This article is cited by
-
Molecular insights into intrinsic transducer-coupling bias in the CXCR4-CXCR7 system
Nature Communications (2023)
-
CXCR7 as a novel therapeutic target for advanced prostate cancer
Oncogene (2023)
-
GPR182 limits antitumor immunity via chemokine scavenging in mouse melanoma models
Nature Communications (2022)
-
Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium
Basic Research in Cardiology (2022)
-
Ackr3-Venus knock-in mouse lights up brain vasculature
Molecular Brain (2021)